Sino Biopharmaceutical Limited (HKG:1177)
Hong Kong
· Delayed Price · Currency is HKD 5.46
-0.02 (-0.36%)
Apr 29, 2026, 4:08 PM HKT
Sino Biopharmaceutical Market Cap
Sino Biopharmaceutical has a market cap or net worth of 97.87 billion as of April 29, 2026. Its market cap has increased by 36.25% in one year.
Market Cap
97.87B
Enterprise Value
103.36B
Revenue
35.43B
Ranking
n/a
PE Ratio
37.94
Stock Price
5.46
Market Cap Chart
Since September 29, 2000, Sino Biopharmaceutical's market cap has increased from 329.97M to 97.87B, an increase of 29,559.00%. That is a compound annual growth rate of 24.91%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sichuan Kelun-Biotech Biopharmaceutical | 115.34B |
| Akeso | 121.22B |
| RemeGen | 75.51B |
| WuXi Biologics | 138.70B |
| Innovent Biologics | 148.88B |
| 3SBio | 56.85B |
| Biocytogen Pharmaceuticals (Beijing) | 46.28B |
| Shanghai Henlius Biotech | 44.97B |